SCHEMBL3919677

SCHEMBL3919677

CCCCCCCCc1ccc(OCC(CBr)CC(=O)O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 7/20 0.52
▸ S1PR2 O95136 4/20 0.52
▸ S1PR4 O95977 5/20 0.50
▸ S1PR3 Q99500 4/20 0.50
▸ S1PR5 Q9H228 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.48
▸ PPARA Q07869 2/20 0.47
▸ PPARG P37231 1/20 0.47
▸ THRA P10827 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ USP2 O75604 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ CASP1 P29466 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ SLCO1B3 Q9NPD5 1/20 0.46
▸ SLCO1B1 Q9Y6L6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3929491 0.79 S1PR1 (0.64) S1PR1S1PR2S1PR4S1PR3S1PR5
SCHEMBL13675777 0.78 S1PR1 (0.51) S1PR1S1PR2S1PR4S1PR3S1PR5
SCHEMBL3997525 0.77 PPARA (0.69) ALDH1A1PPARAPPARG
SCHEMBL446792 0.77 PPARA (0.69) ALDH1A1PPARAPPARG
SCHEMBL5696298 0.77 PPARA (0.69) ALDH1A1PPARAPPARG
SCHEMBL4001417 0.77 PPARA (0.69) ALDH1A1PPARAPPARG
SCHEMBL5696314 0.77 PPARA (0.69) ALDH1A1PPARAPPARG
SCHEMBL2054507 0.75 PPARA (0.67) ALDH1A1PPARAPPARGTHRBLMNA
SCHEMBL28599043 0.75 S1PR1 (0.58) S1PR1S1PR2S1PR4S1PR3ALDH1A1
SCHEMBL3488843 0.74 LMNA (0.68) S1PR1S1PR2S1PR4S1PR3S1PR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7608633-B2 Heteroaryl-substituted acetone derivatives as inhibitors of phospholipase A2 MERCKLE GMBH (DE) 2009-10-27 — — US disclosed
EP-1590324-B1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A sb 2 /sb MERCKLE GMBH (DE) 2009-03-11 — — EP disclosed
US-20060142366-A1 Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2 MERCKLE GMBH (DE) 2006-06-29 — — US disclosed
EP-1590324-A1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A sb 2 /sb MERCKLE GMBH (DE) 2005-11-02 — — EP disclosed
WO-2004069797-A1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A2 MERCKLE GMBH (DE) 2004-08-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060142366-A1 Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2 PLD2, PLA2G1B, PLA2G4A S1PR1 1120/4885S1PR2 448/4885S1PR4 1251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback